Logo

LSH

Lakeside Holding Limited

LSH

Lakeside Holding Limited • NASDAQ
$0.87 ▼ -4.81% (-0.04)
Market Cap $8.14 M
52w High $3.40
52w Low $0.78
Dividend Yield 0%
P/E -1.45
Volume 17.49K
Outstanding Shares 9.37M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $6.1M ▼ $2.38M ▲ $-1.357M ▼ -22.25% ▼ $-0.092 ▲ $-1.078M ▼
Q4-2025 $6.31M ▲ $2.344M ▲ $-893.113K ▲ -14.154% ▲ $-0.11 ▲ $-371.708K ▲
Q3-2025 $3.803M ▲ $1.79M ▼ $-1.071M ▲ -28.156% ▲ $-0.14 ▲ $-862.545K ▲
Q2-2025 $3.596M ▼ $1.922M ▲ $-1.947M ▼ -54.145% ▼ $-0.26 ▼ $-1.998M ▼
Q1-2025 $4.082M $1.85M $-1.335M -32.718% $-0.18 $-725.403K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $4.54M ▼ $18.635M ▲ $11.681M ▲ $6.954M ▲
Q4-2025 $4.956M ▲ $14.405M ▲ $11.56M ▲ $2.846M ▲
Q3-2025 $1.499M ▲ $9.94M ▲ $9.19M ▲ $749.788K ▼
Q2-2025 $1.123M ▼ $9.837M ▼ $8.191M ▲ $1.646M ▼
Q1-2025 $2.739M $10.81M $7.192M $3.618M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-1.357M ▼ $-4.017M ▼ $-108.8K ▼ $3.672M ▲ $-416.424K ▼ $-4.017M ▼
Q4-2025 $-893.113K ▲ $-483.702K ▼ $538.889K ▲ $3.384M ▲ $3.457M ▲ $-522.078K ▼
Q3-2025 $-1.071M ▲ $-238.304K ▲ $123.348K ▲ $487.186K ▲ $375.843K ▲ $-159.731K ▲
Q2-2025 $-1.947M ▼ $-530.216K ▲ $-1.312M ▼ $250.959K ▼ $-1.616M ▼ $-603.017K ▲
Q1-2025 $-1.335M $-1.403M $-38.279K $4.044M $2.616M $-1.441M

Five-Year Company Overview

Income Statement

Income Statement Lakeside is still at an early, almost experimental stage in terms of its profit and loss. Revenue is very small and has not yet scaled meaningfully. Profitability is weak, with a recent shift into a modest net loss after previously hovering around break-even. Because the business is so small, even minor changes in costs, customer volumes, or pricing can swing earnings sharply from one year to the next. Overall, the income statement looks more like that of a company still building out its model rather than one already in steady, mature operations.

Balance Sheet

Balance Sheet The balance sheet is very thin, which is typical for a young or asset-light logistics and platform business but also raises resilience questions. Total assets are small, cash on hand appears limited, and the company has begun to rely on debt, including convertible debt, to fund growth. Equity is minimal, leaving only a narrow cushion to absorb setbacks. This means the company’s financial structure is sensitive: growth depends on continued access to funding, and any prolonged losses could quickly pressure its capital base.

Cash Flow

Cash Flow Reported cash flows are essentially flat, suggesting that the company has not yet built strong, self-sustaining cash generation from its operations. Capital spending also appears very light, in line with a mainly technology- and service-driven model rather than one heavy in physical assets. In practice, this likely means day-to-day activities and expansion are still supported more by external financing than by internally generated cash, which adds uncertainty until the new business lines begin to scale and contribute more predictable inflows.

Competitive Edge

Competitive Edge Lakeside is carving out a focused position rather than trying to compete head-on with global giants. Its strengths lie in specializing in cross-border flows between the U.S. and Asia, especially for e-commerce and social commerce sellers, and in offering end-to-end solutions that bundle freight, customs, warehousing, and fulfillment. The acquisition of a Chinese pharmaceutical distributor adds a second, more regulated and higher-barrier niche, where licensing and expertise can create stickier customer relationships. However, the company is still very small compared with established logistics and healthcare distributors, so its competitive position depends heavily on execution, maintaining strong partnerships, and proving it can scale without losing service quality.

Innovation and R&D

Innovation and R&D Innovation is a clear emphasis. The American Bear Logistics platform is designed as a cloud-based, data-driven engine for managing routes, prices, and shipments, with direct connections into e-commerce systems through APIs. This enables more automated, real-time management of orders and inventory for online sellers and can create a smoother experience than traditional, paper-heavy freight forwarding. On the healthcare side, Lakeside is pushing into specialized pharmaceutical distribution, including handling sensitive products that require careful temperature control. While this looks more like targeted technology and capability building than formal, heavy R&D spending, the strategic direction is clear: use software, data, and regulatory know-how to differentiate in both logistics and pharma distribution.

Summary

Overall, Lakeside looks like a very early-stage, niche logistics and pharmaceutical distribution platform rather than a mature industrial company. Financially, it is small, lightly capitalized, and not yet self-funding, which adds risk and makes results inherently volatile. Strategically, it is pursuing a focused path: combining a tech-enabled cross-border logistics platform with a move into regulated pharmaceutical distribution in China. If it can deepen its technology, expand its network, and integrate the pharma business effectively, it could build a defensible niche. At the same time, its tiny size, reliance on external funding, and the complexity of both logistics and healthcare regulation mean that execution risk and uncertainty remain high.